mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.3 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |